medigraphic.com
SPANISH

Cirugía Plástica

ISSN 2992-8559 (Electronic)
ISSN 1405-0625 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • Policies
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number 2

<< Back Next >>

Cir Plast 2013; 23 (2)

Experience in the management of Dupuytren’s disease

Bertrand-Silva PA, Mondragón-Pinzón EE
Full text How to cite this article

Language: Spanish
References: 6
Page: 101-107
PDF size: 398.25 Kb.


Key words:

Dupuytren’s disease, fasciectomy, nodules, dermofasciectomy.

ABSTRACT

Dupuytren’s disease is a benign fibroproliferative disorder of the palmar fascia six times more common in men than in women. The risk of Dupuytren’s disease increases with age: 7% in the group of 45-59 years to 40% in 70-74 years. Among the risk factors are: alcohol, tobacco, diabetes, epilepsy and hypercholesterolemia. In the Regional Hospital of PEMEX in Poza Rica, from January 2005 to January 2012, eleven patients with Dupuytren’s disease were registered and offered treatment and rehabilitation. A follow-up from three months to two years was carried out. We describe clinical features, results and complications. Dupuytren’s disease may be unilateral or bilateral; nodules usually followed by a thickening in the form of a cord. For fasciectomy, the most commonly used treatment, there are multiple approaches, including midline longitudinal and transverse skin incision. 90.9% of our patients had some degree of improvement, 45.5% developed some degree of functional limitation, and there was a recurrence rate of 30.7%. Management of Dupuytren’s disease requires extensive knowledge of its etiologic factors and pathophysiology given the high rate of recurrence and postoperative complications.


REFERENCES

  1. Saboeiro AP, Porkorny JJ, Shehadi SI, Virgo KS, Johnson FE. Racial distribution of Dupuytren’s disease in Department of Veterans Affairs patients. Plast Reconstr Surg 2000; 106(1): 71-75.

  2. Gudmundsson KG, Arngrímsson R, Sigfússon N, Björnsson A, Jónsson T. Epidemiology of Dupuytren’s disease: clinical, serological, and social assessment. The Reykjavik Study. J Clin Epidemiol 2000; 53(3): 291-296.

  3. Brenner P, Krause-Bergmann A, Ha-Van V. Die Dupuytren-Kontraktur in Norddeutschland. Epidemiologische Erfassungsstudie anhand von 500 Fällen. Unfallchirurg 2012; 104 (4): 303-311.

  4. Picardo NE, Khan WS. Advances in the understanding of the aetiology of Dupuytren’s disease. Surgeon 2012; 10(3): 151-158.

  5. Kakar S, Giuffre J, Skeete K, Elhassan B. Dupuytren’s disease. Orthopaedics and Trauma 2010; 24 (3): 197-206.

  6. Shaw RB Jr, Chong AK, Zhang A, Hentz VR, Chang J. Dupuytren’s disease: history, diagnosis and treatment. Plast Reconstr Surg 2007; 120 (3): 44e-54e.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Cir Plast. 2013;23